Clinical Trial

A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to understand the treatment patterns and clinical outcomes of myelodysplastic syndromes patients treated with luspatercept or erythropoiesis-stimulating agents
Trial Details
NCT Number NCT06971185
Lead Sponsor Bristol-Myers Squibb
Conditions Myelodysplastic Syndromes (MDS)
Enrollment 430 participants
Start Date 2024-11-22
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-14